YEAR	WHAT HAPPENED?
1982	First recombinant DNA drug marketed: human insulin (licensed to Eli Lilly and Company).
1984	First laboratory production of Factor VIII, a clotting factor for bleeding in hemophiliacs.
1985	Genentech received approval from the U.S. Food and Drug Administration (FDA) to produce growth hormone for children with growth hormonne deficiency - the first recombinant pharmaceutical product to be manufactured and marketed by a biotechnology company

 

TOP OF PAGE
BACK TO HOME PAGE